Survival Analysis of Total Therapy 3 in Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM) is a hematologic malignancy that accounts for approximately 1% of all adult cancers. This study investigated the impact of patient distance traveled to MM care sites, which was not considered in previous research on any disease-specific staging or prognostic schema despite evid...
Main Author: | Miller, Scott Edward Bowman |
---|---|
Format: | Others |
Language: | en |
Published: |
ScholarWorks
2015
|
Subjects: | |
Online Access: | https://scholarworks.waldenu.edu/dissertations/1729 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=2833&context=dissertations |
Similar Items
-
Induction therapy in newly diagnosed multiple myeloma: Current research scenario and questions for the future
by: Bhausaheb Bagal, et al.
Published: (2019-01-01) -
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
by: Sarah A. Bird, et al.
Published: (2020-05-01) -
Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities
by: Lee, Saem
Published: (2016) -
Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01) -
Endocarditis due to Gemella haemolysans in a newly diagnosed multiple myeloma patient
by: Dongyan Liu, et al.
Published: (2016-09-01)